Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Assertio Holdings, Inc.

ASRTNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$12.06
$0.22(1.86%)
U.S. Market opens in 13h 54m

Assertio Holdings, Inc. Fundamental Analysis

Assertio Holdings, Inc. (ASRT) shows weak financial fundamentals with a PE ratio of -2.64, profit margin of -21.06%, and ROE of -26.99%. The company generates $0.1B in annual revenue with weak year-over-year growth of -17.83%.

Key Strengths

Cash Position120.94%
PEG Ratio-0.08
Current Ratio1.58

Areas of Concern

ROE-26.99%
Operating Margin-16.94%
We analyze ASRT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -33.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-33.3/100

We analyze ASRT's fundamental strength across five key dimensions:

Efficiency Score

Weak

ASRT struggles to generate sufficient returns from assets.

ROA > 10%
-9.05%

Valuation Score

Excellent

ASRT trades at attractive valuation levels.

PE < 25
-2.64
PEG Ratio < 2
-0.08

Growth Score

Moderate

ASRT shows steady but slowing expansion.

Revenue Growth > 5%
-17.83%
EPS Growth > 10%
95.07%

Financial Health Score

Excellent

ASRT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.37
Current Ratio > 1
1.58

Profitability Score

Weak

ASRT struggles to sustain strong margins.

ROE > 15%
-2698.69%
Net Margin ≥ 15%
-21.06%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ASRT Expensive or Cheap?

P/E Ratio

ASRT trades at -2.64 times earnings. This suggests potential undervaluation.

-2.64

PEG Ratio

When adjusting for growth, ASRT's PEG of -0.08 indicates potential undervaluation.

-0.08

Price to Book

The market values Assertio Holdings, Inc. at 0.72 times its book value. This may indicate undervaluation.

0.72

EV/EBITDA

Enterprise value stands at 12.72 times EBITDA. This signals the market has high growth expectations.

12.72

How Well Does ASRT Make Money?

Net Profit Margin

For every $100 in sales, Assertio Holdings, Inc. keeps $-21.06 as profit after all expenses.

-21.06%

Operating Margin

Core operations generate -16.94 in profit for every $100 in revenue, before interest and taxes.

-16.94%

ROE

Management delivers $-26.99 in profit for every $100 of shareholder equity.

-26.99%

ROA

Assertio Holdings, Inc. generates $-9.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Assertio Holdings, Inc. generates limited operating cash flow of $13.33M, signaling weaker underlying cash strength.

$13.33M

Free Cash Flow

Assertio Holdings, Inc. produces free cash flow of $13.33M, offering steady but limited capital for shareholder returns and expansion.

$13.33M

FCF Per Share

Each share generates $2.08 in free cash annually.

$2.08

FCF Yield

ASRT converts 17.46% of its market value into free cash.

17.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.64

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.58

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.27

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.15

vs 25 benchmark

How ASRT Stacks Against Its Sector Peers

MetricASRT ValueSector AveragePerformance
P/E Ratio-2.6429.28 Better (Cheaper)
ROE-26.99%820.00% Weak
Net Margin-21.06%-19743.00% (disorted) Weak
Debt/Equity0.370.26 Weak (High Leverage)
Current Ratio1.584.69 Neutral
ROA-9.05%-17807.00% (disorted) Weak

ASRT outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Assertio Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-89.90%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

98.16%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-94.58%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ